Inventiva S.A. (IVA)
NASDAQ: IVA · IEX Real-Time Price · USD
3.794
+0.104 (2.82%)
At close: May 17, 2024, 4:00 PM
3.800
+0.006 (0.16%)
After-hours: May 17, 2024, 4:00 PM EDT
Inventiva Market Cap
Inventiva has a market cap or net worth of $198.70 million as of May 17, 2024. Its market cap has increased by 81.46% in one year.
Market Cap
198.70M
Enterprise Value
228.25M
1-Year Change
81.46%
Ranking
Category
Stock Price
$3.79
Market Cap Chart
Since July 10, 2020, Inventiva's market cap has decreased from $512.20M to $198.70M, a decrease of -61.21%. That is a compound annual growth rate of -21.78%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 197.70M | 3.89% |
May 16, 2024 | 190.30M | -2.36% |
May 15, 2024 | 194.90M | 2.47% |
May 14, 2024 | 190.20M | 2.53% |
May 13, 2024 | 185.50M | 5.28% |
May 10, 2024 | 176.20M | -1.45% |
May 9, 2024 | 178.80M | -0.28% |
May 8, 2024 | 179.30M | -0.28% |
May 7, 2024 | 179.80M | 0.56% |
May 6, 2024 | 178.80M | 3.95% |
May 3, 2024 | 172.00M | 3.12% |
May 2, 2024 | 166.80M | -1.24% |
May 1, 2024 | 168.90M | 5.56% |
Apr 30, 2024 | 160.00M | -5.27% |
Apr 29, 2024 | 168.90M | -0.30% |
Apr 26, 2024 | 169.40M | 2.85% |
Apr 25, 2024 | 164.70M | -2.49% |
Apr 24, 2024 | 168.90M | -1.52% |
Apr 23, 2024 | 171.50M | -0.29% |
Apr 22, 2024 | 172.00M | -0.86% |
Apr 19, 2024 | 173.50M | -3.50% |
Apr 18, 2024 | 179.80M | 7.15% |
Apr 17, 2024 | 167.80M | -2.72% |
Apr 16, 2024 | 172.50M | 0.94% |
Apr 15, 2024 | 170.90M | -7.62% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Atossa Therapeutics | 201.74M |
Zevra Therapeutics | 201.73M |
Delcath Systems | 199.77M |
Compugen | 197.86M |
Kodiak Sciences | 196.44M |
Trevi Therapeutics | 194.75M |
Telomir Pharmaceuticals | 194.23M |
YS Biopharma Co. | 193.98M |